ENDO: Gene-Expression Assay IDs Suspicious Thyroid Nodules
A gene-expression classifier that measures expression of 167 genes correctly identifies suspicious thyroid nodules with high sensitivity.
Thyroid Disease
Subclinical Hyperthyroidism Tied to Coronary Heart Disease
Subclinical hyperthyroidism is associated with increased risk of coronary heart disease (CHD) morbidity and mortality; and treatment with levothyroxine for subclinical hypothyroidism is associated with fewer ischemic heart disease (IHD) events in patients aged 40-70 years.
More Complications After Thyroid Surgery in Elderly
Advanced age is a risk factor for complications after thyroidectomy.
Boca Pharmacal Receives Approval for Methimazole Tablets
Boca Pharmacal has received approval from the FDA for Methimazole Tablets USP, the generic version of King Pharmaceutical’s Tapazole tablets.
Antenatal Screening for Hypothyroidism Not Beneficial
Screening for maternal hypothyroidism, and treatment of women with positive results, is not associated with improved IQ in offspring at age 3.
Phase 3 Study of NPSP558 for Hypoparathyroidism in Adults
NPS Pharmaceuticals announced positive results from its Phase 3 REPLACE study of NPSP558 for the treatment of hypoparathyroidism in adults.
Phase 2b study of CTAP101 in chronic kidney disease patients
Cytochroma announced initiation of its Phase 2b study of CTAP101 capsules for the treatment of patients with vitamin D insufficiency, secondary hyperparathyroidism (SHPT), and stage 3 CKD.
Propylthiouracil gains Boxed Warning
The FDA has added a Boxed Warning to the label for propylthiouracil, to include information about reports of severe liver injury and acute liver failure, some of which have been fatal, in adult and pediatric patients using this medication.
